30 Leyte jail inmates infected with COVID-19 | Inquirer News

30 Leyte jail inmates infected with COVID-19

/ 05:42 PM March 31, 2021

TACLOBAN CITY –– At least 30 inmates of the Leyte Sub-Provincial Jail have been infected with the coronavirus disease (COVID-19).

Jelyn Malibago, information officer of the Department of Health (DOH) in Eastern Visayas, said a team from their office went to the jail facility on Friday, March 31, to check the situation.

She said they had yet to determine when and how the infection began.

Article continues after this advertisement

The facility has more than 400 inmates.

FEATURED STORIES

As of Wednesday, the region has 16,587 COVID-19 cases, 329 of them active. It has 16,007 recoveries and 251 deaths.

Meanwhile, the municipal government of Burauen in Leyte announced that its mayor, Juanito Renomeron, has been tested positive for COVID-19.

Article continues after this advertisement

Work at the municipal building has been suspended beginning Friday until further notice.

LZB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: COVID-19, inmates, Tacloban City

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.